Joanna Pilch

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsSeparation technologiesCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2024
In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot-β-cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers.

Joanna Pilch, Agnieszka Potęga, Patrycja Kowalik

|Jan 21, 2023
pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy.

Joanna Pilch, Agnieszka Potęga, Agata Kowalczyk

|May 28, 2022
A Novel Method of Endotoxins Removal from Chitosan Hydrogel as a Potential Bioink Component Obtained by CO2 Saturation.

Adrianna Banach-Kopeć, Szymon Mania, Joanna Pilch

|Feb 15, 2022
Foliate-Targeting Quantum Dots-β-Cyclodextrin Nanocarrier for Efficient Delivery of Unsymmetrical Bisacridines to Lung and Prostate Cancer Cells.

Joanna Pilch, Patrycja Kowalik, Agata Kowalczyk

|Mar 06, 2021
Quantum Dots as a Good Carriers of Unsymmetrical Bisacridines for Modulating Cellular Uptake and the Biological Response in Lung and Colon Cancer Cells.

Joanna Pilch, Patrycja Kowalik, Piotr Bujak

|Mar 27, 2020
New Unsymmetrical Bisacridine Derivatives Noncovalently Attached to Quaternary Quantum Dots Improve Cancer Therapy by Enhancing Cytotoxicity toward Cancer Cells and Protecting Normal Cells.

Joanna Pilch, Edyta Matysiak-Brynda, Agata Kowalczyk

Pageof 2

Frequent Collaborators

5 joint publications

Anna Maria Nowicka

4 joint publications

Ewa Augustin

3 joint publications

Agata Kowalczyk

3 joint publications

Artur Kasprzak